M. Albarrán

Hit to lead evaluation of 1,2,3-triazolo[4,5-b]pyridines as PIM kinase inhibitors.

J. Oyarzábal, J. Fominaya, N. Ajenjo, 2012, Bioorganic & medicinal chemistry letters.

Rapid identification of ETP-46992, orally bioavailable PI3K inhibitor, selective versus mTOR.

M. Barbacid, F. Mulero, P. Pizcueta, 2012, Bioorganic & medicinal chemistry letters.

Identification of ETP-46321, a Potent and Orally Bioavailable PI3K α, δ Inhibitor.

M. Barbacid, F. Mulero, P. Pizcueta, 2012 .

Imidazo[1,2-a]pyrazines as novel PI3K inhibitors.

O. Rabal, J. Oyarzábal, J. Bischoff, 2012, Bioorganic & medicinal chemistry letters.

Omipalisib inspired macrocycles as dual PI3K/mTOR inhibitors.

J. Oyarzábal, C. Blanco-Aparicio, R. Álvarez, 2020, European journal of medicinal chemistry.

Identification of ETP-46321, a potent and orally bioavailable PI3K α, δ inhibitor.

M. Barbacid, F. Mulero, P. Pizcueta, 2012, Bioorganic & medicinal chemistry letters.